Joe Pariseau

Company: C4 Therapeutics

Job title: Director, Clinical Development Sciences

Seminars:

Driving Progress for an Oral BRD9 Bifunctional Degrader 10:00 am

Identifying potent, selective, and orally bioavailable BiDAC™ degrader of BRD9 Showcasing a world-class degrader platform demonstrates effective degradation of previously undruggable target Presenting initial clinical data for dose finding escalation cohortsRead more

day: Day 1